Original language | English (US) |
---|---|
Pages (from-to) | 1198-1201 |
Number of pages | 4 |
Journal | Journal of the American Academy of Dermatology |
Volume | 81 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2019 |
ASJC Scopus subject areas
- Dermatology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of the American Academy of Dermatology, Vol. 81, No. 5, 11.2019, p. 1198-1201.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Association between prurigo nodularis and malignancy in middle-aged adults
AU - Larson, Valerie A.
AU - Tang, Olive
AU - Stander, Sonja
AU - Miller, Lloyd S.
AU - Kang, Sewon
AU - Kwatra, Shawn G.
N1 - Funding Information: Conflicts of interest: Dr Miller has received grant support from AstraZeneca, MedImmune (a subsidiary of AstraZeneca), Pfizer, Boerhinger Ingelheim, Regeneron Pharmaceuticals, Moderna Therapeutics; is a shareholder of Noveome Biotherapeutics; and is on the scientific advisory board of Integrated Biotherapeutics, which are all unrelated to the work reported in this article. Dr Kwatra is an advisory board member for Menlo and Trevi Therapeutics. Ms Larson, Ms Tang, Dr Stander, and Dr Kang have no conflicts of interest to disclose. Funding sources: None. Conflicts of interest: Dr Miller has received grant support from AstraZeneca, MedImmune (a subsidiary of AstraZeneca), Pfizer, Boerhinger Ingelheim, Regeneron Pharmaceuticals, Moderna Therapeutics; is a shareholder of Noveome Biotherapeutics; and is on the scientific advisory board of Integrated Biotherapeutics, which are all unrelated to the work reported in this article. Dr Kwatra is an advisory board member for Menlo and Trevi Therapeutics. Ms Larson, Ms Tang, Dr Stander, and Dr Kang have no conflicts of interest to disclose. Funding Information: Conflicts of interest: Dr Miller has received grant support from AstraZeneca, MedImmune (a subsidiary of AstraZeneca), Pfizer, Boerhinger Ingelheim, Regeneron Pharmaceuticals, Moderna Therapeutics; is a shareholder of Noveome Biotherapeutics; and is on the scientific advisory board of Integrated Biotherapeutics, which are all unrelated to the work reported in this article. Dr Kwatra is an advisory board member for Menlo and Trevi Therapeutics. Ms Larson, Ms Tang, Dr Stander, and Dr Kang have no conflicts of interest to disclose.
PY - 2019/11
Y1 - 2019/11
UR - http://www.scopus.com/inward/record.url?scp=85064925874&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064925874&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2019.03.083
DO - 10.1016/j.jaad.2019.03.083
M3 - Article
C2 - 30954580
AN - SCOPUS:85064925874
SN - 0190-9622
VL - 81
SP - 1198
EP - 1201
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 5
ER -